Association of CYP2C9 Genetic Variants with Vitiligo

BACKGROUND: Vitiligo is a depigmenting skin disorder in which genetic factors play an important role. OBJECTIVE: To examine the association of CYP2C9 *1/*2/*3 gene polymorphism with vitiligo. METHODS: In this case controlled study, 95 Saudi patients with vitiligo (50 men and 45 women), with a mean age of 27.3 years, were analyzed. Patients were compared to 86 healthy controls from the same locality (76 men and 10 women), with a mean age of 20.1 years. In all participants, DNA was extracted and processed for characterization of 2C9 *1/*2/*3 gene variants using real time-polymerase chain reaction. RESULTS: Vitiligo patients have a significantly higher CYP2C9 *3 allele carriage rate compared to controls (32.7% versus 4.7%, p=0.00, odds ratio=9.9, 95% confidence interval=3.3~29.6). On the other hand, frequencies of CYP2C9 *2 genotypes and alleles did not show any significant difference between vitiligo cases and controls. When the frequencies of CYP2C9 genotypes were compared among subgroups of age, gender, family history, and disease patterns, the cases with positive consanguinity had significantly higher frequencies of homozygous genotypes than others (p=0.029). CONCLUSION: CYP2C9 *3 allele carriage is probably associated with vitiligo susceptibility.

Lymphocytes DNA content, p53, C-MYC and BCL-2 as predictive markers in childhood with acute lymphoblastic leukemia

Cell cycle parameters as well as apoptotic and tumor markers directly control cell growth. DNA ploidy and S phase fraction, apoptosis fraction in addition to apoptotic inducer [p53, c-myc] and antiapoptotic marker [Bcl-2] were investigated in childhood with acute lymphoblastic leukemia [ALL] leukemia as a predictive markers represented in survival data. This study included 70 children with [ALL]; 38 males and 32 females; of median age 5 years. Event free survival [EFS] and overall survival [OS] were estimated for all studied cases. Cell cycle and apoptotic parameters as well as p53, c-myc and Bcl-2 were analyzed using FACS caliber flow cytometer in the lymphocyte cells of peripheral blood. Aneuploidy constituted 33% of studied cases. The median overall survival [OS] showed higher significant values when S% was <4.5%, and DNA index was >/= 0.94 and p53 was < 70.87, whereas it showed no significant difference related to G0/G1%, G2/M% and aneuploidy%. The median event free survival [EFS] showed significant higher value at Bcl-2 >/= 81.5 but with no significance related to other cell cycle parameters as well as p53 and c-myc. These data suggest that DNA index, S phase fraction, p53 and BcI-2 may be useful as a predictive markers that help patients' stratification and adjusting protocols of ALL therapy